₹ 1,668.30
43.90 (2.70%)
T
Tatva Chintan Pharma
₹ 1,668.30
Tatva Chintan Pharma EPS Summary (consolidated)
The latest quarterly EPS of Tatva Chintan Pharma as of Q2 Sep 2026 stands at ₹9.17. This is a 34.26% growth quarter on quarter and 116.27% growth same quarter last year. For the FY2026 the EPS of Tatva Chintan Pharma stands at ₹17.98. This is a 636.89% growth compared with FY2025.
Tatva Chintan Pharma EPS

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






